CONTACT US
Home > Browse by topic > Apoptosis

Apoptosis Expert Witnesses

Apoptosis, the biological process of programmed cell death, sits at the center of a substantial body of pharmaceutical and biotechnology research, and disputes in this field typically arise wherever that research intersects with commercial development. Patent litigation often involves claims over apoptosis-related drug targets, mechanisms of action, or diagnostic methods used in oncology, immunology, and neurodegenerative disease research. Licensing and collaboration disputes between biotechnology companies, research institutions, and pharmaceutical partners can also turn on whether apoptosis-related discoveries were properly attributed, disclosed, or commercialized under the parties' agreement. Regulatory compliance questions, particularly around FDA approval pathways for therapies targeting apoptotic pathways, frequently underlie business disputes over development timelines and product claims. At the center of most disputes is whether a technology, discovery, or regulatory submission performed, and was characterized, as the parties represented.

An apoptosis expert helps counsel interpret dense molecular biology data — signaling pathway research, cell death assay results, and target validation studies — and translate that science into evidence a court can evaluate. In patent disputes, experts can assess whether a claimed drug target, mechanism, or diagnostic method meets patent claim limitations or departs from prior art in the apoptosis research literature. In licensing and collaboration disputes, experts can evaluate whether the scientific work performed matches what was represented under a research or development agreement. Experts can also address causation questions tied to drug efficacy or diagnostic performance, connecting laboratory and preclinical data to the claims at issue. This scientific grounding allows litigators to press patent, licensing, or regulatory claims with the technical credibility such cases demand.

Because apoptosis research spans applications from oncology and immunology to neurodegenerative disease, matching an expert's specific research background to the technology at issue is critical to a credible presentation. The apoptosis professionals Round Table Group can provide have worked as researchers and physicians at universities, hospitals, and research facilities, with experience spanning cancer biology, signal transduction, and cell death pathways relevant to a range of therapeutic areas, and several have published extensively and testified on related patent and scientific matters. We've completed more than 75,000 expert searches for litigators, and we apply that experience to identify candidates whose specific research background fits your case. Let us help you find the right apoptosis expert for your case by calling us at (202) 908-4500.

Kinds of Cases We Work On

Round Table Group helps our clients find a wide variety of Apoptosis expert witnesses for cases like:

01

Apoptosis Spike Sinks Biologics Manufacturing Yield.

A biopharmaceutical sponsor sued the contract manufacturing organization it had engaged to scale up production of a monoclonal antibody, alleging an unexplained spike in cell culture apoptosis during commercial-scale bioreactor runs caused yield losses that delayed the drug's launch. We identified experts with experience in bioprocess cell biology, bioreactor scale-up analysis, and cell culture apoptosis mechanisms. A shift in the nutrient feed schedule during scale-up had triggered a stress-induced apoptotic response absent at the original development scale, supporting a settlement covering remediation and lost production time.
02

Mismeasured Apoptosis Assay Delays IND Filing.

A drug developer sued the contract toxicology laboratory it had engaged to run IND-enabling safety studies, alleging the lab's caspase-3 activation assay results used to assess drug-induced apoptosis in target organs were unreliable, forcing repetition of a substantial share of the required studies. We identified experts with experience in apoptosis assay methodology, toxicology laboratory quality control, and IND-enabling study validation standards. The laboratory had failed to run required positive control samples in most disputed batches, invalidating their quantitative results, supporting a settlement covering the repeated studies and filing delay.
03

CAR-T Release Testing Dispute Turns on Apoptosis.

A cell therapy manufacturer disputed with the hospital-based sponsor that had contracted it to produce a CAR-T cell product, after the manufacturer rejected a completed lot based on an apoptosis marker assay indicating excessive cell death, while the sponsor argued the rejection cost it a critical treatment window. We identified experts with experience in cellular therapy release testing, apoptosis marker assay interpretation, and CAR-T manufacturing specification analysis. The disputed lot's apoptosis marker levels fell within the historical range of previously released lots that had performed acceptably in patients, supporting a settlement revising the release specification threshold.
04

Annexin V Assay Licensing Dispute Erupts.

A diagnostics company sued a competitor, alleging its newly launched apoptosis detection kit used a proprietary Annexin V conjugate formulation the diagnostics company had licensed exclusively to a different manufacturer. We identified experts with experience in apoptosis detection technology, Annexin V conjugate chemistry, and diagnostic kit formulation comparison. The competitor's conjugate matched the licensed technology's specific fluorophore-to-protein ratio and buffer composition beyond what independent development would produce, supporting a settlement requiring reformulation or direct licensing.
05

Apoptosis Biomarker Failure Sinks Diagnostic Partnership.

A pharmaceutical company sued its companion diagnostic development partner, alleging its apoptosis-based biomarker assay, intended to identify patients likely to respond to an investigational oncology drug, failed to achieve the analytical validation performance specified in their co-development agreement. We identified experts with experience in apoptosis biomarker validation, companion diagnostic development standards, and oncology assay reproducibility analysis. The assay's reproducibility across repeated measurements of the same samples fell meaningfully short of the specified threshold in most of the validation cohort, supporting a settlement covering the cost of a replacement developer.
06

Buyer Says Apoptosis Data Was Concealed.

A large pharmaceutical company sued the sellers of an oncology biotech it had acquired, alleging the sellers withheld unfavorable apoptosis assay data indicating the lead drug candidate's mechanism of action was substantially weaker than represented. We identified experts with experience in apoptosis pharmacology, oncology drug mechanism of action assessment, and M&A scientific due diligence review. Internal reports had documented a markedly lower rate of tumor cell apoptosis at the clinical dose months before closing, never reflected in the diligence materials, supporting a substantial post-closing purchase price adjustment.
07

University Sues Over Stalled Apoptosis Drug.

A university technology transfer office sued the biotechnology licensee of one of its patented apoptosis-inducing small molecule compounds, alleging the licensee had failed to use the commercially reasonable development efforts the license agreement required. We identified experts with experience in apoptosis-targeted drug development, small molecule development benchmarking, and licensing diligence obligations. The licensee had allocated a development budget far below what comparable sponsors devoted at a similar stage with no documented rationale, supporting a settlement terminating the license and returning rights to the university.
08

Former Scientist Accused of Assay Theft.

A biotechnology company sued a former senior research scientist and the competitor she joined, alleging she had taken the company's proprietary high-throughput apoptosis screening protocol and data analysis algorithm to accelerate the competitor's drug discovery program. We identified experts with experience in high-throughput apoptosis screening methodology, drug discovery assay design, and trade secret comparison analysis. The competitor's assay conditions and scoring algorithm matched the original's proprietary parameter set beyond what independent development would produce, supporting a preliminary injunction.
09

Flow Cytometry Lab's Data Integrity Questioned.

A biopharmaceutical sponsor sued the contract laboratory running flow cytometry-based apoptosis assays for a pivotal clinical trial, alleging systemic data integrity lapses forced exclusion of a substantial share of patient samples from the efficacy analysis. We identified experts with experience in flow cytometry quality standards, apoptosis assay data integrity auditing, and clinical trial laboratory compliance. The laboratory had failed to perform required calibration checks before running most disputed batches, introducing measurement drift inconsistent with the protocol, supporting a settlement covering the trial extension needed to reach statistical power.
10

Potency Assay Dispute Voids Batch Release.

A biologics manufacturer disputed with the buyer of a completed drug substance batch after the buyer's quality team rejected the lot based on an apoptosis-based potency assay indicating cell-killing activity fell below specification, while the manufacturer argued the buyer's reference standard was improperly calibrated. We identified experts with experience in bioassay potency testing, reference standard stability analysis, and biologics batch release specification review. The buyer's reference standard had degraded beyond its validated stability window, producing an artificially inflated potency requirement the lot had actually met, supporting reversal of the rejection in arbitration.

Here are a few of our favorite Apoptosis Expert Witnesses:

Maryland Mitochondria, Apoptosis Expert #15081

I have 33 years of experience in the field of membrane biophysics with specific knowledge of mitochondrial function, channel formation and apoptosis. I have published on such topics as channel formation by ceramide, voltage-gating of mitochondrial channels and the dynamics of molecular machines.

 

California Autophagy, Apoptosis Expert #19606

I have 10 years of experience in the field of biology, with specific knowledge of stress-induced autophagy, DNA damage-induced apoptosis and breast cancer tumorigenesis. I have published on such topics as science, cell and genes, and development.

 

Texas Cell Signaling, Apoptosis Expert #19815

I have 20 years of experience and specialize in the field of biochemistry, with specific knowledge of detoxification of electrophilic compounds and drugs, drug transport, multi-drug resistance in cancer cells, mechanisms of cell signaling and synthetic organic chemistry.

 

California Apoptosis, Tumor Necrosis Factor Expert #20895

I have 18 years of experience, and specialize in the field of apoptosis with specific knowledge in the areas of tumor necrosis factor (TNF) receptor family, orphan steroid receptor and T cells. I have published on such topics as T cell development, Fas and TRAIL-R. I have testified on TNF related family.

 

New Jersey Apoptosis, Cell Death Expert #21038

I have 15 years of experience, and specialize in the field of cell, molecular, and developmental biology with specific knowledge in the areas of cancer biology, embryology (stem cells). I have published on such topics as breast cancer research and apoptosis.

 

Your Case Deserves The Best Apoptosis Expert Witnesses

Registered icon

The right expert witnesses and consulting experts can make your case. That’s why we have spent so many hours over the past quarter century making sure our clients have just the right expert team — whether one expert or many, early-stage advice or expert reports and testimony. Across over 50,000 expert search assignments, we have honed a unique, customized approach to identifying, analyzing and connecting with expert talent so you can focus on winning your case.

LET US HELP YOU

Apoptosis, Kidney Disease Expert #22492

I have 20 years of experience, and specialize in the field of endocannabinoids and lipoxygenase with specific knowledge in the areas of metabolism, signal transduction and impact on human pathologies. I have published on such topics as neurodegenerative disorders, platelet activation and spontaneous abortion. I have testified on endocannabinoid transport, endocannabinoid degradation and endocannabinoid activity.

 

Tennessee Apoptosis, Caspases, Cell Cycle Expert #24124

I have 20 years of experience and specialize in the field of cancer biology, with specific knowledge of apoptosis, cell division and tumor cell metastasis. I have published on such topics as apoptosis, transcription, and splicing and cell division.

 

Nebraska Signal Transduction, Apoptosis Expert #27940

I have 20 years of experience, and specialize in the field of molecular and cellular biology, ophthalmology with specific knowledge in the areas of cataractogenesis, molecular biology and cell biology and cancer. I have published on such topics as gene structure and function, cataract mechanism, telomerase and aging, MAP kinase and phosphatases and apoptosis, alphacrystallin. I have testified on Raf kinases as drug target, phosphatases as drug targets and alpha-crystallin as drug candidates.

 

Colorado Radiation Biology, Apoptosis Expert #32595

I have 32 years of experience, and specialize in the field of radiation biology with specific knowledge in the areas of mutagenesis, radiation carcinogenesis and flow cytometry. I have published on such topics as hyperthermia, mutagenesis and cell cycle analysis.

 

Colorado Apoptosis, Caspase Expert #36369

I have 15 years of experience in the field of cancer research, with specific knowledge of cancer biology, target therapy, and signaling transduction. I have published on such topics as cancer research and oncogene.

 

Ohio Alzheimer Disease, Apoptosis Expert #46018

I have 13 years of experience, and specialize in the field of neurodegenerative diseases with specific knowledge in the areas of alzheimer disease, parkinson disease and amyotrophic lateral sclerosis. I have published on such topics as mitochondrial dysfunction, oxidative stress and signal transduction.

 

Put Our Apoptosis Expert Network to Work for You

Registered icon

Our huge network of experts – eminent university professors and practitioners who have achieved renown as thought leaders in their fields – combined with unparalleled research capabilities puts the experts you need at your disposal when and where you need them.

If you’re a litigator or general counsel, we want to put this network to work for you and your clients. Let us know how we can help by calling us at (202) 908-4500 or filling out the form on this page. We’re so confident you’ll love what we do that unless you retain an expert we present there’s no charge!

LET US HELP YOU

Questions Attorneys Ask About Apoptosis Expert Witnesses:

Counsel typically need an apoptosis expert when a case involves patent claims over drug targets, mechanisms of action, or diagnostic methods tied to programmed cell death research in oncology, immunology, or neurodegenerative disease. These experts are also valuable in licensing and collaboration disputes between biotechnology companies and research partners, and in regulatory disputes involving FDA submissions for therapies targeting apoptotic pathways. Early engagement helps counsel frame discovery around the specific molecular biology at issue.
Search again

GET STARTED FINDING THE RIGHT EXPERT WITNESS

Spend your time working with your experts, not searching for them! We're here to de-stress the process of having a great expert witness team so that it’s easy to have the right experts every time. We'll conduct a quick but thorough search and deliver a roster of top candidates for you to review. There's no charge for the custom search — you pay only the hourly rate if you retain one of our experts.

  • This field is for validation purposes and should be left unchanged.

Or call 202-908-4500 or email us.

Related topics

Biology
Biomedical Science
Cell Biology
Drug Delivery
Gene Therapy
Genetics
Health
Health Care
Neurology
Ophthalmology
Therapy